- Recent Funding
- Investors
- ZOLL Medical Corporation
ZOLL Medical Corporation portfolio
ZOLL Medical Corporation has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is Impulse Dynamics's $80M Series B+ round in December 2019, alongside Amzak Health Investors, Wellington Management, Acorn Capital and 3 others. That company is in Health and bio.
What ZOLL Medical Corporation invests in
- Health and bio · 1 · 100%
How ZOLL Medical Corporation invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $80M |
ZOLL Medical Corporation portfolio companies
IImpulse Dynamics$80MSeries B+ · Dec 2019
| Company | Round with ZOLL Medical Corporation | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $80M | $140M | Dec 10, 2025 round |
Most frequent co-investors
WWellington Management1 shared round · last Dec 1, 2019
AAmzak Health Investors1 shared round · last Dec 1, 2019
AAcorn Capital1 shared round · last Dec 1, 2019
- AAbiomed1 shared round · last Dec 1, 2019
- MMINTH Group1 shared round · last Dec 1, 2019
- KKennedy Lewis Investment Management1 shared round · last Dec 1, 2019
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name ZOLL Medical Corporation. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists ZOLL Medical Corporation, which is a subset of its real portfolio. API: /api/v1/investors/zoll-medical-corporation (get a free API key). More: the most active VC firms and new venture capital funds.